Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
RH Bophelo Limited primarily allocates its capital within the healthcare industry in South Africa. The company's investment strategy focuses on equity, quasi-equity, and other equity-linked instruments, targeting operational infrastructure across various sub-sectors. These include health insurance, private hospital facilities, pharmaceuticals, and the retail and distribution networks. The firm was established in 2016, with its headquarters located in Johannesburg, South Africa, and operates as a subsidiary of Public Investment Corporation SOC Limited.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD.